Structure-Based Design of Promysalin Analogues to Overcome Mechanisms of Bacterial Resistance.

ABSTRACT: The search for antibiotics that function through novel mechanisms of action is ongoing, and recent progress in our lab identified the tricarboxylic acid cycle as a viable option. Promysalin is a secondary metabolite capable of species-specific inhibition of Pseudomonas aeruginosa, a common opportunistic pathogen. Promysalin disrupts primary metabolism in this bacterium by competitively inhibiting succinate dehydrogenase at the ubiquinone binding site. However, the activity of promysalin in cellulo is marred potentially by its chemical instability and/or propensity for efflux. To assess the success of these novel analogues, a novel strain of P. aeruginosa harboring gene deletions of eight efflux pumps and porins was developed and implemented. Herein, we disclose the synthesis

SUBMITTER: Mahoney AR 

PROVIDER: S-EPMC10077553 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature